Cell-level gene mosaics are linked to Alzheimer’s
Not all cells in your body read their genes the same way. Even in healthy tissue, neighboring cells can activate different versions of the same gene. New research maps this mosaic pattern across the genome and links it directly to Alzheimer’s disease, Parkinson’s, and other conditions.
Researchers characterized more than one hundred locations in the human genome where cells within the same tissue express genes from one allele, the opposite allele, both, or neither, in a pattern that is stable within a single cell but differs unpredictably between cells. The study, published in eLife, named these locations Inactivation/Stability Centers (I/SCs) and found they contain numerous genes associated with serious disease, including Alzheimer’s, Parkinson’s, epilepsy, and congenital deafness.
This phenomenon, called allele-specific gene expression, is already well known for imprinted genes and immune genes regulated by allelic exclusion. What’s new is the scale: hundreds of additional locations across the autosomal genome show the same behavior. The pattern is also found at syntenic locations in the mouse genome, suggesting an evolutionarily conserved regulatory mechanism.
Why this may matter for aging
Cellular mosaicism, the condition in which cells within the same organism differ in their genetic activity, is thought to increase with age as epigenetic patterns become less stable. If allele-specific regulation at I/SC locations shifts over time, cells carrying a risk allele in the active position may accumulate in older tissues. The researchers suggest this could be a mechanism by which genetic risk factors manifest clinically only later in life. This interpretation is preliminary and requires longitudinal validation.
What the study does and doesn’t show
The findings are observational. The study describes where allele-specific regulation occurs and which disease-linked genes sit within these zones, but it does not establish a causal chain from mosaicism to disease onset. Whether correcting allele-specific expression could be therapeutically useful is an open question. Larger population studies and longitudinal designs will be needed to test these ideas further.
Want to research this yourself?
Search for example:
- allele-specific gene expression aging
- cellular mosaicism disease
- epigenetic allelic regulation